Covid-19 in France: for the vacinal recall, the public prefers Pfizer to Moderna

Audio 01:14

The French public is looking to have Pfizer-BioNTech vaccines rather than Moderna for the third dose.

© Daniel LEAL / AFP

Text by: RFI Follow

1 min

The vaccine booster campaign against Covid-19 is in full swing.

And for good reason, for lack of a third dose of vaccine, the health pass for over 18s will no longer be valid as of January 15.

But if the public responds, it remains attentive to what is injected into the body.

He is even more and more demanding.

Advertising

Read more

With

At the Porte de Versailles vaccinodrome in southern Paris, patients are flocking in hopes of getting their booster dose.

When entering the huge building, a question often comes up: "

"

Many in the queue would prefer to be vaccinated with a dose of Pfizer.

The treatment of the German laboratory is more reassuring in the eyes of patients.

But in this center, as in many others, it is based on stocks: the country has 6 million doses of Pfizer / BioNTech, against 20 million Moderna.

Failing to get what she wanted, Nawel, 42, prefers to turn around: “

 "

A Moderna vaccine with more side effects

If the High Authority for Health considers the Moderna vaccine effective, it recognizes side effects that are a little stronger and more likely.

For this reason, Christian's doctor, 54, prescribed him specifically Pfizer / BioNTech.

He prefers to come home empty-handed and try his luck in a pharmacy, where he will have the choice.

But on condition of being patient.

No vaccination on Sundays for pharmacists who are already exhausted

Lucie Bouteloup

►

Newsletter

Receive all international news directly in your mailbox

I subscribe

Follow all the international news by downloading the RFI application

google-play-badge_FR

• France

• Health and medicine